Product
Anti-CD19 CAR T-cells
1 clinical trial
6 indications
Indication
Acute Lymphoblastic LeukemiaIndication
Acute Lymphoblastic Leukemia in ChildrenIndication
acute adultIndication
B-cell Acute Lymphoblastic LeukemiaIndication
Diffuse Large B-cell LymphomaIndication
CARClinical trial
CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility ProtocolStatus: Recruiting, Estimated PCD: 2025-12-01